Back
Rocket Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RCKT
Rocket Pharmaceuticals
Last Price:
$7.23
Seasonality Move:
24.16%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and RCKT is experiencing slight selling pressure.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.87 | Buy |
| 20-day SMA: | 6.18 | Buy |
| 50-day SMA: | 7.96 | Sell |
| 200-day SMA: | 14.39 | Sell |
| 8-day EMA: | 6.86 | Buy |
| 20-day EMA: | 6.75 | Buy |
| 50-day EMA: | 7.87 | Sell |
| 200-day EMA: | 13.25 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 52.85 | Buy |
| Chaikin Money Flow: | -423675 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.45 - 7.71) | Buy |
| Bollinger Bands (100): | (7.45 - 12.35) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 7.23 while RCKT 8-day simple moving average is 6.87, which is a Buy signal.
-
The stock price of RCKT is 7.23 while Rocket Pharmaceuticals 20-day SMA is 6.18, which makes it a Buy.
-
Rocket Pharmaceuticals 50-day simple moving average is 7.96 while RCKT share price is 7.23, making it a Sell technically.
-
RCKT stock price is 7.23 and Rocket Pharmaceuticals 200-day simple moving average is 14.39, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
28
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a SellThe current Rocket Pharmaceuticals [RCKT] share price is $7.23. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
770.9M
Price in USD:
7.23
Share Volume:
1.6M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
26.98
52-Week Low:
4.55
Sell
28
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?The Rocket Pharmaceuticals stock price is 7.23 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
-
Rocket Pharmaceuticals share price is 7.23 while RCKT 8-day exponential moving average is 6.86, which is a Buy signal.
-
The stock price of RCKT is 7.23 while Rocket Pharmaceuticals 20-day EMA is 6.75, which makes it a Buy.
-
Rocket Pharmaceuticals 50-day exponential moving average is 7.87 while RCKT share price is 7.23, making it a Sell technically.
-
RCKT stock price is 7.23 and Rocket Pharmaceuticals 200-day simple moving average is 13.25, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.04 per share, an increase this year of $0.64 per share, and an increase next year of $0.54 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Rocket Pharmaceuticals is a Sell
-
Rocket Pharmaceuticals Relative Strength Index (RSI) is 52.85, which suggest Rocket Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rocket Pharmaceuticals is (5.45 - 7.71), which suggest Rocket Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals is (7.45 - 12.35), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.